Insights from early adopters, patients, payers and clinicians shows the reality of genomics in healthcare today. Discover new methods in patient communication, pricing & return of results.
Oncologists, clinicians, counselors & those at a strategic level - directors, executives, managers of hospitals and health care centers.
Heidi Rehm, Chief Laboratory Director, Partners Healthcare Personalized Medicine
David Bick, Medical Director, The Smith Family Clinic for Genomic Medicine.
From TOPMed to machine learning and up through the clouds to the heights of best practice cases to prevent information overload, genomic data on vast scales holds the key to know and do more.
Computational biologists, bioinformaticians and anyone analyzing, storing or sharing data. These individuals come from academic, drug development and healthcare backgrounds.
Anthony Phillippakis, Chief Data Officer, Broad Institute
Enoch Huang, Head of Computational Sciences, Pfizer R&D
Right through the pipeline, genomics has the power to enrich drug development strategy, redefine efficacy and reduce cost and attrition rates.
Senior leadership down to research scientists from large pharma and small to medium drug development companies.
Join us to explore how with speakers including;
Sally John, VP of Genomics & Computational Biology, Biogen
Andy Plump, CMSO, Takeda
From single cells to synthetic systems, build insights in CRISPR, single cell analysis, lab management and data sharing in the R&D track.
Principal Investigators, professors, post-docs and research scientists.
Speakers announced include:
Noel Burtt, Associate Director, Diabetes Research, Broad Institute of MIT & Harvard
Toby Bloom, Deputy Scientific Director, Informatics, New York Genome Center.